Journals / Epilepsi / 2018 / Cilt: 24 - Sayı: 2

Band Heterotopia and Lennox-Gastaut Syndrome: A Case Report

Bant Heterotopi ve Lennox-Gastaut Sendromu: Olgu Sunumu

Journal
Epilepsi
Pages
83–86
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case of a 17-year-old male patient with drug-resistant tonic, atonic, myoclonic, atypical absence seizures, and behavioral abnormalities who was diagnosed with LGS was presented to highlight the difficulty in treatment management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heterotopia, referred to as a limited or common neuronal migration disorder, may manifest clinically with mild mental retardation, epileptic seizures, psychiatric symptoms, or systemic disorders.
📊
Key Findings & Data:Approximately 90% of cases have drug-resistant epileptic seizures.
💡
Conclusion & Impact:This case of a 17-year-old male patient with drug-resistant tonic, atonic, myoclonic, atypical absence seizures, and behavioral abnormalities who was diagnosed with LGS was presented to highlight the difficulty in treatment management.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Heterotopia, referred to as a limited or common neuronal migration disorder, may manifest clinically with mild mental retardation, epileptic seizures, psychiatric symptoms, or systemic disorders. Approximately 90% of cases have drug-resistant epileptic seizures. Lennox-Gastaut syndrome (LGS) is an epileptic encephalopathy with cognitive impairment; it is treatment-resistant and has a poor prognosis, with multiple patterns of seizures and specific electroencephalographic (EEG) patterns. In this case, the brain imaging showed band heterotopy, an EEG 2–2.5 Hz spike wave, and multiple spike and fast rhythms. This case of a 17-year-old male patient with drug-resistant tonic, atonic, myoclonic, atypical absence seizures, and behavioral abnormalities who was diagnosed with LGS was presented to highlight the difficulty in treatment management.

Özet

Sınırlı veya yaygın bir nöronal migrasyon bozukluğu olarak adlandırılan heterotopi hafif mental retardasyon, epileptik nöbetler, psikiyatrik belirtiler veya sistemik bozukluklarla klinikte kendini gösterebilir. Olguların yaklaşık %90’ında, çoğunlukla tedaviye dirençli epileptik nöbetler gözlenir. Lennox-Gastaut sendromu (LGS) çok sayıda nöbet tipinin birlikte görüldüğü, özel elektroensefalografi (EEG) paternlerine sahip, kognitif etkilenmenin de olduğu, tedaviye dirençli ve kötü prognozlu bir epileptik ensefalopatidir. Bu yazıda tedaviye dirençli tonik, atonik, miyoklonik, atipik absans nöbetleri ve davranış anormallikleri olan, beyin görüntülemesinde bant heterotopiye sahip, EEG’si 2–2.5 hz diken dalga, multipl diken ve hızlı ritimlerden oluşan LGS tanısı koyduğumuz 17 yaşındaki erkek olgu tedavi yönetimindeki zorluğa dikkat çekmek için sunulmuştur.

🔖

Cite This Article

GÖL, M. F., ERDOĞAN, F. F. (2018). Band Heterotopia and Lennox-Gastaut Syndrome: A Case Report. Epilepsi, Cilt: 24 - Sayı: 2, 83–86. https://ajindex.com/articles/197154

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Guerrini R. Epilepsy in children. Lancet 2006;367(9509):499– 524. Archila R, Papazian O. Lennox-Gastaut syndrome [Article in Spanish]. Rev Neurol 1999;29(4):346–9.
  2. Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009;8(1):82–93. Yapıcı Z. Sinir Sisteminin Doğumsal Hasarları ve Gelişimsel Hastalıkları [online]. Available at: http://www.itfnoroloji.org/ dogumsal/dogumsal.htm. Markand ON. Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 2003;20(6):426–41.
  3. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007;9(4):353–412.
  4. Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 1997;337(25):1807–12.
  5. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. A double-blind, randomized trial of topiramate in LennoxGastaut syndrome. Topiramate YL Study Group. Neurology 1999;52(9):1882–7.
  6. Dulac O, N’guyen T. The Lennox-Gastaut syndrome. Epilepsia 1993;34 Suppl 7:S7–17. Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with LennoxGastaut syndrome. Neurology 2008;(21):1950–8.
  7. Illum N, Taudorf K, Heilmann C, Smith T, Wulff K, Mansa B, et al. Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome. Neuropediatrics 1990;21(2):87–90.
  8. Hughes JR, Patil VK. Long-term electro-clinical changes in the Lennox-Gastaut syndrome before, during, and after the slow spike-wave pattern. Clin Electroencephalogr 2002;33(1):1–7.
  9. Ohtsuka Y, Amano R, Mizukawa M, Ohtahara S. Long-term prognosis of the Lennox-Gastaut syndrome. Jpn J Psychiatry Neurol 1990;44(2):257–64.
  10. Ekici A, Yarar C, Yakut A, Çarman KB, Yimenicioğlu S. Clinical evaluation and long term prognosis of patients with LennoxGastaut syndrome. Türk Ped Arfl 2012;47(1):47–51.